Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

C R Bard Inc (NYSE:BCR)

308.34
Delayed Data
As of 4:02pm ET
 +1.08 / +0.35%
Today’s Change
203.63
Today|||52-Week Range
309.16
+37.25%
Year-to-Date
C.R. Bard (BCR) Up 1.6% Since Earnings Report: Can It Continue?
10:29am / Zacks.com - Paid Partner Content
Becton (BDX) Announces $4.5B Follow-On Share Offerings
May 11 / Zacks.com - Paid Partner Content
CR Bard (BCR) Hits a 52-Week High: What's Driving the Stock?
May 15 / Zacks.com - Paid Partner Content
Becton Dickinson: meeting expectations
Apr 24 / FT.com - Paid Partner Content

Today’s Trading

Previous close307.26
Today’s open307.28
Day’s range307.28 - 308.77
Volume1,015,116
Average volume (3 months)857,026
Market cap$22.3B
Dividend yield0.34%
Data as of 4:02pm ET, 05/23/2017

Growth & Valuation

Earnings growth (last year)+297.18%
Earnings growth (this year)+14.29%
Earnings growth (next 5 years)+11.19%
Revenue growth (last year)+8.72%
P/E ratio39.2
Price/Sales4.55
Price/Book13.37

Competitors

 Today’s
change
Today’s
% change
ZBHZimmer Biomet Holdin...+0.02+0.02%
TFXTeleflex Inc+0.86+0.43%
BSXBoston Scientific Co...-0.13-0.49%
WSTWest Pharmaceutical ...-0.28-0.29%
Data as of 4:02pm ET, 05/23/2017

Financials

Next reporting dateJuly 25, 2017
EPS forecast (this quarter)$2.84
Annual revenue (last year)$3.7B
Annual profit (last year)$528.8M
Net profit margin14.24%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Timothy M. Ring
President, Chief Operating Officer &
Director
John H. Weiland
Corporate headquarters
Murray Hill, New Jersey

Forecasts